Both in Pharmaceuticals
Trevi Therapeutics vs First Tracks Biotherapeutics
Over the past year TRVI returned −15.0% and TRAX returned +25.5%; their daily moves had a correlation of 0.55.
TRVI −15.0% TRAX +25.5%Growth of $1, one year, split-adjusted
| Metric | TRVI | TRAX |
|---|---|---|
| Price | $13.52 | $45.72 |
| Market cap | $1.93B | $1.92B |
| Today | +1.27% | +0.75% |
| 1 month | −6.2% | +27.1% |
| 6 months | −2.2% | — |
| Year to date | +8.0% | — |
| 1 year | +28.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $318.9M | $168.0M |
| Dividend yield | — | — |
| Volatility (60d) | 39.2% | — |
| Short % of float | 14.4% | 21.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).